无肺损伤的急性脑损伤患者中肺保护性通气的神经与呼吸效应:脑通气单中心随机干预研究
该前瞻性交叉随机研究纳入30例颅内压正常且无肺损伤的急性脑损伤插管患者,随机接受低潮气量(6 ml/kg预测体重)联合低PEEP(5 cmH2O)或高PEEP(12 cmH2O),每次干预间恢复基线通气(潮气量9 ml/kg预测体重、PEEP 5 cmH2O)。最终分析27例(脑出血、创伤性脑损伤、蛛网膜下腔出血),其中6例达到安全上限(颅内压>22 mmHg持续>5分钟)而需中断至少一次干预。未中断干预者中,从基线到低潮气量/低PEEP和低潮气量/高PEEP的颅内压变化分别为2.2 mmHg和2.3 mmHg,认为临床不相关;干预未显著影响脑自动调节或氧合。中断事件与高基线颅内压(p<0.001)、低脑代偿储备(p<0.01)和机械功率(p<0.05)相关;两种干预的跨肺驱动压均为5±2 cmH2O,通过调整呼吸频率将动脉血二氧化碳分压维持在34-36 mmHg,故二氧化碳变化与颅内压升高无关。
要点
- 无肺损伤的急性脑损伤患者中,大多数对低潮气量(6 ml/kg预测体重)联合高PEEP(12 cmH2O)耐受良好,颅内压变化小(低PEEP组2.2 mmHg、高PEEP组2.3 mmHg),临床不相关。
- 6/27例(近四分之一)患者颅内压升高超过安全上限(>22 mmHg持续>5分钟),需中断至少一次干预。
- 中断事件与高基线颅内压(p<0.001)、低脑代偿储备(p<0.01)和机械功率(p<0.05)相关,可用于个体化通气设置。
- 干预未显著影响脑自动调节或氧合;跨肺驱动压两种干预均为5±2 cmH2O。
- 通过调整呼吸频率将动脉血二氧化碳分压维持在34-36 mmHg,二氧化碳变化与颅内压升高无关。
适用人群与场景
- 急性脑损伤(脑出血、创伤性脑损伤、蛛网膜下腔出血)插管患者,颅内压正常且无肺损伤。
诊断标准与关键阈值
- 安全上限:颅内压>22 mmHg持续>5分钟需中断干预。
- 基线通气:潮气量9 ml/kg预测体重、PEEP 5 cmH2O;低潮气量:6 ml/kg预测体重;低PEEP:5 cmH2O;高PEEP:12 cmH2O。
- 动脉血二氧化碳分压目标范围34-36 mmHg,通过调整呼吸频率维持。
处置流程与药物剂量
- 随机接受低潮气量(6 ml/kg预测体重)联合低PEEP(5 cmH2O)或高PEEP(12 cmH2O),每次干预间恢复基线通气(潮气量9 ml/kg预测体重、PEEP 5 cmH2O)。
- 持续监测气道压和跨肺压评估呼吸力学;通过外部脑室引流或脑实质探头记录颅内压。
- 颅内压>22 mmHg持续>5分钟时中断干预。
红旗征与不能漏的情况
- 颅内压>22 mmHg持续>5分钟需中断干预。
- 高基线颅内压(p<0.001)、低脑代偿储备(p<0.01)和机械功率(p<0.05)与干预中断事件相关。
研究设计与关键结果
- 前瞻性交叉随机研究纳入30例,分析27例(脑出血、创伤性脑损伤、蛛网膜下腔出血),6例达到安全上限需中断至少一次干预。
- 未中断干预者中,从基线到低潮气量/低PEEP和低潮气量/高PEEP的颅内压变化分别为2.2 mmHg和2.3 mmHg,临床不相关。
- 干预未显著影响脑自动调节或氧合。
- 中断事件与高基线颅内压(p<0.001)、低脑代偿储备(p<0.01)和机械功率(p<0.05)相关。
- 两种干预的跨肺驱动压均为5±2 cmH2O;动脉血二氧化碳分压维持在34-36 mmHg,二氧化碳变化与颅内压升高无关。
证据类型、等级与局限
- 证据类型:前瞻性、交叉、单中心随机干预研究(NCT03278769,注册于2017年9月12日)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为基线颅内压、脑代偿储备和机械功率可预测肺保护性通气的潜在有害效应,并可用于个体化呼吸机设置。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Lung protective ventilation (LPV) comprising low tidal volume (VT) and high positive end-expiratory pressure (PEEP) may compromise cerebral perfusion in acute brain injury (ABI). In patients with ABI, we investigated whether LPV is associated with increased intracranial pressure (ICP) and/or deranged cerebral autoregulation (CA), brain compensatory reserve and oxygenation.
METHODS: In a prospective, crossover study, 30 intubated ABI patients with normal ICP and no lung injury were randomly assigned to receive low VT [6 ml/kg/predicted (pbw)]/at either low (5 cmH2O) or high PEEP (12 cmH2O). Between each intervention, baseline ventilation (VT 9 ml/kg/pbw and PEEP 5 cmH2O) were resumed. The safety limit for interruption of the intervention was ICP above 22 mmHg for more than 5 min. Airway and transpulmonary pressures were continuously monitored to assess respiratory mechanics. We recorded ICP by using external ventricular drainage or a parenchymal probe. CA and brain compensatory reserve were derived from ICP waveform analysis.
RESULTS: We included 27 patients (intracerebral haemorrhage, traumatic brain injury, subarachnoid haemorrhage), of whom 6 reached the safety limit, which required interruption of at least one intervention. For those without intervention interruption, the ICP change from baseline to "low VT/low PEEP" and "low VT/high PEEP" were 2.2 mmHg and 2.3 mmHg, respectively, and considered clinically non-relevant. None of the interventions affected CA or oxygenation significantly. Interrupted events were associated with high baseline ICP (p < 0.001), low brain compensatory reserve (p < 0.01) and mechanical power (p < 0.05). The transpulmonary driving pressure was 5 ± 2 cmH2O in both interventions. Partial arterial pressure of carbon dioxide was kept in the range 34-36 mmHg by adjusting the respiratory rate, hence, changes in carbon dioxide were not associated with the increase in ICP.
CONCLUSIONS: The present study found that most patients did not experience any adverse effects of LPV, neither on ICP nor CA. However, in almost a quarter of patients, the ICP rose above the safety limit for interrupting the interventions. Baseline ICP, brain compensatory reserve, and mechanical power can predict a potentially deleterious effect of LPV and can be used to personalize ventilator settings. Trial registration NCT03278769 . Registered September 12, 2017.
参考来源
- Beqiri E, Smielewski P, Guérin C, et al. Neurological and respiratory effects of lung protective ventilation in acute brain injury patients without lung injury: brain vent, a single centre randomized interventional study. Crit Care. 2023. PMID: 36941683. doi:10.1186/s13054-023-04383-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。